64
Participants
Start Date
September 21, 2023
Primary Completion Date
September 21, 2028
Study Completion Date
September 21, 2028
Pemetrexed
Pemetrexed will be administered intravenously
Cisplatin
Cisplatin will be administered intravenously
Carboplatin
Possible substitution with carboplatin based on clinician discretion
RECRUITING
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RECRUITING
Memorial Sloan Kettering Westchester (Limited Protocol Activites), Harrison
RECRUITING
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale
RECRUITING
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
RECRUITING
Allegheny Health Network (Data Collection Only), Pittsburgh
NOT_YET_RECRUITING
University of Michigan (Data Collection Only), Ann Arbor
RECRUITING
University of Chicago (Data Collection Only), Chicago
NOT_YET_RECRUITING
Washington University (Data Collection Only), St Louis
NOT_YET_RECRUITING
University of Nebraska (Data collection only), Omaha
RECRUITING
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
RECRUITING
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
RECRUITING
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
NOT_YET_RECRUITING
Rutgers University (Data Collection Only), New Brunswick
Memorial Sloan Kettering Cancer Center
OTHER